As in most complex neurodegenerative disorders, there is wide genetic heterogeneity between patients, with several genes and variants implicated, including mutations in the microtubule-associated protein tau gene (MAPT), the progranulin gene (GRN), and repeat expansion in the C9ORF72 gene; these three genes account for nearly 75% of all familial FTD cases. The gene discussed is MAPT; the disease is frontotemporal dementia.